Buico, Eunn Kayden B.
HRN: 27-17-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/20/2025
05/27/2025
IV
435mg
Q6H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes